FDA panel examines link between breast cancer, pill, says more research needed.
D000569:Americas; D001695:Biology; D001943:Breast Neoplasms; D003257:Consumer Product Safety; D003267:Contraception; D003268:Contraception Behavior; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D019049:Developed Countries; D004194:Disease; D005193:Family Planning Services; D006077:Government Agencies; D007722:Health Knowledge, Attitudes, Practice; D006287:Health Planning Guidelines; D007878:Legislation as Topic; D009369:Neoplasms; D009656:North America; D009938:Organizations; D012307:Risk Factors; D014481:United States
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined
Americas; Biology; Breast Cancer; Cancer; Contraception; Contraceptive Methods; Contraceptive Usage; Developed Countries; Diseases; Family Planning; Government Agencies; Legislation; Neoplasms; North America; Northern America; Oral Contraceptives; Oral Contraceptives, Combined; Oral Contraceptives, Phasic; Organizations; Previous Practice; Product Approval; Recommendations; Risk Factors; United States